Linde Bangladesh Ltd
Linde Bangladesh Ltd exhibits a strong equity position with a debt-to-equity ratio of 0.01, indicating minimal leverage and a conservative capital structure. However, the company's liquidity position is constrained, as evidenced by a negative free cash flow of -2,300,428,000 BDT and a cash and equivalents balance of only 20,000 BDT, which is insufficient to cover its long-term debt of 29,182,000 BDT. The current ratio of 1.7 suggests the company can cover its short-term liabilities, but the negative net cash position raises concerns about its ability to fund operations without external financing. Profitability metrics show a return on equity (ROE) of 1.84 and a return on assets (ROA) of 1.08, both of which are below the industry median for Commodity Chemicals, indicating that the company is underperforming relative to its peers in terms of asset and equity utilization. The operating margin, calculated as operating income of 8,013,860,000 BDT on revenue of 2,214,080,000 BDT, is exceptionally high at 361.5%, which is anomalous and likely due to a data error or misclassification. The company's revenue is distributed across three segments: Bulk Gases, Packaged Gas and Products (PG&P), and Healthcare. While the financial snapshot does not provide segment-specific revenue figures, the Healthcare segment is likely a significant contributor given the company's focus on medical gas supply and pipeline systems. The geographic exposure is concentrated in Bangladesh, with no disclosed international operations, which increases the company's vulnerability to local economic and regulatory changes. Looking ahead, the company is expected to maintain a stable revenue trajectory, with the current fiscal year (FY) and next FY outlooks not indicating significant growth or contraction. The capital expenditure of -209,696,000 BDT suggests a reduction in investment, which may impact long-term growth potential. The risk assessment highlights liquidity as a medium concern, with the company's free cash flow being negative and its cash reserves insufficient to cover debt obligations. Recent events, including the latest financial filings and transcripts, do not indicate any material changes in the company's operations or strategic direction. The last actual EPS was reported at 58.04 BDT, and the last actual revenue was 4,873,004,000 BDT, both of which are sourced from analyst estimates.
Business. Linde Bangladesh Ltd is engaged in the manufacturing and supply of industrial and medical gases, anesthesia and ancillary equipment, and welding electrodes, operating through three segments: Bulk Gases, Packaged Gas and Products (PG&P), and Healthcare.
Classification. Linde Bangladesh Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92.
- Linde Bangladesh Ltd has a conservative capital structure with a low debt-to-equity ratio of 0.01.
- The company's liquidity is constrained, with a negative free cash flow and minimal cash reserves.
- Profitability metrics, including ROE and ROA, are below industry medians, indicating underperformance.
- Revenue is concentrated in Bangladesh, increasing exposure to local economic and regulatory risks.
- The company's capital expenditure is negative, suggesting a reduction in investment and potential long-term growth constraints.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.